Cargando…
Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption
BACKGROUND: Bone resorption is initiated by osteoclastic acidification of the resorption lacunae. This process is mediated by secretion of protons through the V-ATPase and chloride through the chloride antiporter ClC-7. To shed light on the intracellular signalling controlling extracellular acidific...
Autores principales: | Sørensen, Mette G, Karsdal, Morten A, Dziegiel, Morten H, Boutin, Jean A, Nosjean, Olivier, Henriksen, Kim |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978137/ https://www.ncbi.nlm.nih.gov/pubmed/20977756 http://dx.doi.org/10.1186/1471-2474-11-250 |
Ejemplares similares
-
Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption - implications for osteoclast quality
por: Neutzsky-Wulff, Anita V, et al.
Publicado: (2010) -
Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes
por: Löfvall, Henrik, et al.
Publicado: (2018) -
Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption
por: Ariza, Yuko, et al.
Publicado: (2019) -
Osteoclasts secrete osteopontin into resorption lacunae during bone resorption
por: Luukkonen, Jani, et al.
Publicado: (2019) -
Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice
por: Aljohani, Hanan, et al.
Publicado: (2021)